Hikma Pharmaceuticals profit halves in 2022 on Generics impairment
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business. Read More